[ad_1]
Within the notices, issued on Wednesday, the regulator stated the net platforms had been doing the enterprise in contravention of the Medicine and Cosmetics Act, 1940. They had been advised to file their response inside two days.
It wasn’t clear whether or not the e-pharmacies have responded to the notices, a replica of which ET has seen.
The notices state that the sale, or inventory or exhibit or supply on the market or distribution of medication by way of on-line, web or different digital platforms with no licence has potential affect on the standard of medication and pose danger to public well being resulting from potential misuse of medication by way of self-medication and indiscriminate use of medication.
A number of circumstances are pending in courts requesting prohibition of on-line sale of medication.
The DCGI stated that even after directions from the apex regulator for compliance of an order of Delhi Excessive Court docket, the e-pharmacies had been discovered to be engaged in promoting medicines on-line with out licence.
The excessive courtroom had handed an order by which the respondents had been injuncted from on-line sale of medicines until additional orders. Subsequently, the DCGI forwarded the Delhi HC order to drug controllers in all states and union territories in 2019 and earlier this month for vital motion and compliance.
[ad_2]
Source link
